Expert Addresses Need for Quality of Life to Factor Into Bladder Cancer Immunotherapy Strategies – Targeted Oncology
Targeted Oncology |
Expert Addresses Need for Quality of Life to Factor Into Bladder Cancer Immunotherapy Strategies
Targeted Oncology The therapeutic landscape for patients with metastatic urothelial carcinoma (mUC) is being rapidly altered by clinical trials of immunotherapy, but overall survival could be dramatically improved simply by changing the way quality of life (QoL) is … |
